23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals
Genetic data was on the auction block, and a U.S. biotech company ponied up the cash. New York-based Regeneron Pharmaceuticals announced on Monday that it has purchased DNA testing company 23andMe through a bankruptcy auction